Clinical Trial Update: A Multi-site Study of Autologous Cord Blood Cells for Hypoxic Ischemic Encephalopathy [Phase 2]

View source ↗

Summary

Phase 2 trial update for autologous cord blood cells in neonatal hypoxic-ischemic encephalopathy. The study has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neonatal Hypoxic Ischemic Encephalopathy

Drugs mentioned

• Autologous cord blood cells

Snippet

Sponsor: Michael Cotten | Conditions: Moderate or Severe Hypoxic-ischemic Encephalopathy in Newborns | Phase 2 | Status: COMPLETED | Results posted: 2020-08-25